Case ReportPrimary Angiosarcoma of the Ovary: A Case Report and Review of the Literature☆
References (20)
- et al.
Treatment of primary ovarian angiosarcoma with ifosfamide and doxorubicin
Gynecol Oncol
(1994) - et al.
Malignant lymphangioma of the ovary
Am J Obstet Gynecol
(1943) - et al.
Angiosarcoma associated with germ cell tumors
Hum Pathol
(1985) - et al.
Mesna, doxorubicin, ifosfamide and dacarbazine chemotherapy for ovarian mixed mullerian sarcoma: report of four cases
Gynecol Oncol
(1995) - et al.
Corpus: Mesenchymal Tumors
- et al.
Gynecological sarcomas
Semin Surg Oncology
(1994) - et al.
Angiosarcoma: a report of 67 patients and review of the literature
Cancer
(1996) - et al.
Angiosarcoma of skin and soft tissue: a study of forty-four cases
Cancer
(1981) - et al.
Angiosarcomas of the uterus and ovary: clinicopathologic report
Cancer
(1972)
Cited by (29)
Sarcoma of vulva, vagina and ovary
2011, Best Practice and Research: Clinical Obstetrics and GynaecologyCitation Excerpt :The remaining four women had unknown stage of disease. Even though overall survival for all women ranged from 18 days to 9 years, 12 out of 13 women with stage III and stage IV disease died within 1 year of diagnosis.24–30 Most common treatment approaches for women with advanced-stage disease include full staging surgery (if possible) and a variety of chemotherapy regimens based on doxorubicin plus ifosfamide or paclitaxel.
Spontaneous hemothorax: A comprehensive review
2008, ChestCitation Excerpt :Angiosarcoma is a rare tumor of endothelial cells that originates in small blood vessels. It can affect any organ, but it usually occurs in skin, soft tissue, breast, and visceral organs.71,72 The most common metastatic site for angiosarcoma is the lung; therefore, pulmonary complications such as hemoptysis, pneumothorax, hemothorax, atelectasis, and postobstructive pneumonia have been reported in the literature both from primary thoracic and metastatic angiosarcomas.73–75
Primary angiosarcoma of the ovary: A case report of stage I disease
2005, Gynecologic OncologyPregnancy following recurrent angiosarcoma of the ovary - A case report and review of literature
2005, Gynecologic OncologyOvarian Sarcomas
2004, Gynecologic Cancer: Controversies in ManagementNatural product inhibitors of ovarian neoplasia
2003, Phytomedicine
- ☆
The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Army, Department of the Navy, or the Department of Defense.